<p>Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections</p>-Reference-Cited by-同舟云学术

Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections

Published:2020-04 Issue: Volume:Volume 12 Page:191-200
ISSN:1178-6981
Container-title:ClinicoEconomics and Outcomes Research
language:en
Short-container-title:CEOR

Author:

McCann Eilish^ORCID,Sung Anita H,Ye Gang^ORCID,Vankeepuram Latha,Tabak Ying P

Publisher

Informa UK Limited

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Reference26 articles.

1. International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

2. The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998–2011

3. Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012

4. World Health Organization. Antimicrobial resistance—global report on surveillance;2014. Available from: http://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf. Accessed October 16, 2018.

5. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013; 2013. Available from: https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed March 28, 2019.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriateness of antibiotic prescribing for urinary tract infection in the emergency department of a tertiary care hospital;Clinical Epidemiology and Global Health;2024-05

2. The Prevalence and Association of Different Uropathogens Detected by M-PCR with Infection-Associated Urine Biomarkers in Urinary Tract Infections;Research and Reports in Urology;2024-01

3. A Diagnostic Test Combining Molecular Testing with Phenotypic Pooled Antibiotic Susceptibility Improved the Clinical Outcomes of Patients with Non-E. coli or Polymicrobial Complicated Urinary Tract Infections;Research and Reports in Urology;2023-05

4. Urinary Tract Infections: The Current Scenario and Future Prospects;Pathogens;2023-04-20

5. A single- and multiple-dose study to characterize the pharmacokinetics, safety, and tolerability of ceftolozane/tazobactam in healthy Chinese participants;International Journal of Antimicrobial Agents;2023-03